
Monday, August 01, 2022 9:23:49 PM
Recent ACAD News
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 09/22/2023 10:23:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/19/2023 10:31:39 PM
- Acadia Pharmaceuticals Appoints Albert Kildani as Senior Vice President, Investor Relations and Corporate Communications • Business Wire • 09/19/2023 08:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/15/2023 05:06:45 PM
- Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences • Business Wire • 08/30/2023 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/23/2023 11:31:23 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/21/2023 03:15:59 PM
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 08/14/2023 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2023 08:23:56 PM
- Acadia Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operating Overview • Business Wire • 08/02/2023 08:05:00 PM
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 08/01/2023 11:30:00 PM
- Acadia Pharmaceuticals Appoints Kevin R. Oliver, Ph.D., as Senior Vice President, Chief Business Officer • Business Wire • 07/24/2023 08:05:00 PM
- Acadia Pharmaceuticals to Announce Second Quarter Financial Results on August 2, 2023 • Business Wire • 07/19/2023 08:04:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/18/2023 10:00:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2023 08:01:32 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/14/2023 03:33:21 PM
- Friday’s Wall Street Highlights: JPMorgan Chase, Coinbase, UPS, Theseus Pharmaceuticals, and more • IH Market News • 07/14/2023 11:51:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/14/2023 12:27:47 AM
- Acadia Pharmaceuticals Acquires Ex-North American Rights to Trofinetide and Global Rights to Neuren’s NNZ-2591 in Rett Syndrome and Fragile X Syndrome • Business Wire • 07/13/2023 08:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/13/2023 02:42:59 PM
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 06/26/2023 09:00:00 PM
- Acadia Pharmaceuticals Announces Phase 3 Development Candidate ACP-101 (intranasal carbetocin) for Prader-Willi Syndrome • Business Wire • 06/13/2023 08:05:00 PM
- Nature Medicine Publishes Results from Pivotal Phase 3 LAVENDER™ Study Evaluating DAYBUE™ (trofinetide) Efficacy and Safety in Patients with Rett Syndrome • Business Wire • 06/08/2023 03:10:00 PM
- Acadia Pharmaceuticals to Present at the Jefferies Global Healthcare Conference • Business Wire • 06/01/2023 01:04:00 PM
- Acadia Pharmaceuticals Reports First Quarter 2023 Financial Results and Operating Overview • Business Wire • 05/08/2023 08:05:00 PM
FEATURED Cannabix's MSBS Marijuana Breathalyzer Technology Advances Quantification of THC in Breath • Oct 3, 2023 8:50 AM
Good Gaming, Inc. Announces Galactic Acres™ as Its First Mobile Game Integrated with Web3 Technology • GMER • Oct 3, 2023 8:30 AM
HealthLynked Announces Patent Filing for ARI: A Revolutionary AI-Powered Healthcare Interface • HLYK • Oct 3, 2023 8:00 AM
Nate's Food Co Successfully Completes Cancellation of 1 Billion Common Shares, Paving the Way for a Bright Future • NHMD • Oct 3, 2023 8:00 AM
Branded Legacy Expands Facility to 11,000 Sqft, Extends LOI for Acquisition of The Alcannabist LLC • BLEG • Oct 3, 2023 8:00 AM
Image Protect Announces Memorandum of Understanding for Pending New Business Acquisition • IMTL • Oct 2, 2023 8:14 AM